Operating profit before deduction of amortization: Gossamer Bio (GOSS)
Gossamer Bio, Inc. (GOSS) develops specific immune therapies for the treatment of severe lung pathologies, ensuring long-term patent protection. High demand for innovation amid the inefficiency of current standards guarantees complete patient retention. The operating cash flow confirms the stability of processes, where the metric level is 0.00. Gossamer Bio, Inc. (GOSS) is establishing an indispensable scientific hub in the treatment of pulmonary hypertension, improving the quality of life for patients.
Gossamer Bio (GOSS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
GOSS - Company Net Income|Company Profit Forecast Gossamer Bio, Inc.|GOSS - P/E Multiple|Forward P/E Multiple gossamerbio.com|GOSS - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Gossamer Bio|GOSS - Operating profit EBITDA|Net earnings per one share for the last twelve months Gossamer Bio|GOSS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months gossamerbio.com|GOSS - Net earnings per share growth this year|Expected earnings per share trend next year Gossamer Bio, Inc.
Summary company analytics:GOSS, Gossamer Bio Corp.
Absolute operating profit measures daily liquidity inflow, excluding non-cash depreciation and amortization expenses. The EBITDA trend reflects the business's actual ability to maintain sales momentum. The calculation model reacts instantaneously to updated financial reports, identifying asset overvaluation risks. For Gossamer Bio, Inc. (GOSS), this indicator is critical for financing the development of seralutinib. The stability of this metric determines the company's survival in the clinical trial race.
Competitors of Gossamer Bio, Inc. (GOSS)
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Operating profit before depreciation charges Vera Corp (VERA)|Dianthus Therapeutics (DNTH) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Tourmaline Bio Inc (TRML) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|Operating income before deduction of amortization Pharming Corp|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating profit EBITDA upstreambio.com UPB|ZBIO - Profit before payment of interest, taxes and amortization|Immunome Inc (IMNM) - Operating profit before deduction of amortization|KALV: Operating profit EBITDA|Profit before interest, taxes and amortization Septerna Pharma (SEPN)|Profit before payment of interest, taxes and amortization Pieris Pharmaceuticals|SVRA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization RIGL (Rigel Pharmaceuticals, Inc.)|ANAB (AnaptysBio Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATXS (Astria Pharma)|enGene Corp - Profit before payment of interest, taxes and amortization|RAPT Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics, Inc. (ACRS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Kyverna Therapeutics Inc. (KYTX)|Operating profit before deduction of amortization TLSA|CABA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA VTYX|Operating income before deduction of amortization theratech.com|Profit before payment of interest, taxes and amortization Avalo Therapeutics AVTX|ELDN: Operating profit before amortization|Agenus Inc - Operating profit EBITDA|Climb Bio, Inc (CLYM) - Operating profit before deduction of amortization|ZURA (Zura Bio) - Operating profit before deduction of amortization|ATYR - Operating income before deduction of amortization|ADAG (Adagene Inc) - Operating profit EBITDA|IMA - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|EQ - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Connect Biopharma Holdings Limited CNTB|Operating income before deduction of amortization Immunic Therapeutics (IMUX)|ATRA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InflaRx N.V. IFRX|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Operating profit EBITDA|INMB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc. (KZR)|Profit before payment of interest, taxes and amortization SAB Biotherapeutics, Inc SABS|Income before deduction of interest, taxes and amortization AKTX|ENLV - Profit before payment of interest, taxes and amortization|Q32 Bio Inc. (QTTB) - Operating profit before deduction of amortization|GOVX: Operating profit EBITDA|Edesa Biotech Inc (EDSA) - Operating profit EBITDA|Operating profit before deduction of amortization IBIO|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating income before deduction of amortization boltbio.com|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|APVO - Operating profit before deduction of amortization|AIM - Profit before payment of interest, taxes and amortization|Aditxt (ADTX) - Operating profit before deduction of amortization|GRI (GRI Bio, Inc.) - Operating profit before deduction of amortization|xortx.com (XRTX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before amortization REVB (Revelation Biosciences Inc)|Operating profit EBITDA INDP|SCNI - Profit before interest, taxes and amortization|Operating profit EBITDA CALI (CalciMedica)|Operating profit before depreciation charges Affimed NV|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|ITOS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|tcbiopharm.com (TCBP) - Operating income before deduction of amortization|Operating profit EBITDA THRD
